Bengaluru (Karnataka) [India], June 24 (ANI/NewsVoir): As India battles the second phase of COVID-19, Herbalife Nutrition has pledged more than USD 1 million to aid the country in its fight against the pandemic.
New Delhi [India], June 23 (ANI): The Centre on Wednesday approved further allocation of additional foodgrain to National Food Security Act (NFSA) beneficiaries under Pradhan Mantri Garib Kalyan Yojana (Phase IV) till November.
Indore (Madhya Pradesh) [India], June 23 (ANI): FMCG major Dabur India on Wednesday started construction of its largest facility being set up here with a phased investment of Rs 550 crore to manufacture a range of food products, ayurvedic medicines and health supplements.
Saint John's [Antigua and Barbuda], June 23 (ANI): President of Cricket West Indies, Ricky Skerritt, has confirmed that CWI, the Board of Control for Cricket in India (BCCI), and the Caribbean Premier League (CPL) are engaged in talks for a tweaked CPL schedule to accommodate the second phas
New Delhi [India], June 22 (ANI): Union Minister Piyush Goyal on Tuesday said that soon there will be the soft launch of the first phase of the national single window system.
New Delhi [India], June 22 (ANI): The Drugs Controller General of India (DCGI) is likely to approve Phase III trial data of Covaxin on Tuesday, sources said.
New Delhi, (Delhi), [India], June 22 (ANI/NewsVoir): Despite the setback suffered on the economic front due to the onslaught of COVID-19 pandemic, there are some signs of the revival of economic activities as the country has entered the unlock phase. The industry has also derived its optimis
New Delhi, (Delhi), [India], June 22 (ANI/NewsVoir): After the success of the first phase, CyberPeace Foundation and WhatsApp today announced the launch of the second phase of its 'Cyber Ethics and Online Safety Program' for students. The program will be extended to Assam, Rajasthan and Guja
New Delhi [India], June 22 (ANI): Bharat Biotech's Covaxin has shown 77.8 per cent efficacy after the Subject Expert Committee (SEC) under the drug regulator reviewed its Phase III trials data on Tuesday, according to sources.
New Delhi [India], June 22 (ANI): The Subject Expert Committee (SEC) under the drug regulator will discuss reviewing the Phase III data of Bharat Biotech's Covaxin on Tuesday.
New Delhi [India], June 21 (ANI): The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech submitted data from the Phase III clinical trials of Covaxin to Drugs Controller General of India (DCGI) over the weekend, according to government sources.
New Delhi [India], June 20 (ANI): More than 29.10 crore (29,10,54,050) vaccine doses have been provided to States ad Union Territories so far by the central government (free of cost channel) and through direct state procurement category, the Union Health Ministry said.